Search

everythinglearnresearchcommunity

for

Search:↓

The document did not provide specific information on Telogen Effluvium.

Hair loss in a woman with eosinophilia-myalgia syndrome improved after stopping L-tryptophan and starting treatment.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The document's conclusion cannot be provided because the content is not accessible.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Accurate diagnosis is crucial to distinguish telogen effluvium from male pattern baldness to avoid unnecessary treatments.

Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Modern therapies, like fractional laser, effectively treat telogen effluvium.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Allergic scalp reactions can cause temporary hair loss.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Critically ill patients may experience temporary hair loss after a fever.

COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.